Alfresa Holdings Corp <2784.T>-2008/09 parent

May 12 (Reuters) -

ALFRESA HOLDINGS CORP

PARENT-ONLY FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

Year ended Year ended Year to

Mar 31, 2009 Mar 31, 2008 Mar 31, 2010

LATEST YEAR-AGO COMPANY

RESULTS RESULTS FORECASTS
Sales 13.50 10.88

(+24.1 pct) (+32.4 pct)
Operating 12.03 9.63

(+25.0 pct) (+35.9 pct)
Recurring 12.11 9.65

(+25.6 pct) (+36.8 pct)
Net 13.22 9.56

(+38.2 pct) (+56.9 pct)
EPS Y314.56 Y233.06
Annual div Y87.00 Y83.00 Y88.00
-Q2 div Y45.00 Y41.00 Y44.00
-Q4 div Y42.00 Y42.00 Y44.00

NOTE - Alfresa Holdings Corp was created in September 2003 by integrating operations of drug wholesalers Fukujin and Azwell.

If there is no Q1 or Q3 dividend, Q2 will in most cases
correspond to the first-half dividend and Q4 to the second-half
dividend announced before a new corporate law in 2006 allowed
companies to pay and report dividends on a quarterly basis.

For latest earnings estimates made by Toyo Keizai, please
double click on 2784.TK1.